Medical Policies
- Alphabetical
-
Administrative Anesthesiology Allergy/Immunology Behavioral Health Cardiovascular Dermatology Durable Medical Equipment (DME) Ear, Nose, and Throat (ENT) Endocrinology Gastroenterology General Surgery Genetics Genitourinary Hematology/Oncology Infectious Diseases Laboratory/Pathology Nephrology Neurology/Neurosurgery Obstetrics and Gynecology Ophthalmology Oral maxillofacial Orthopedic Pediatrics Pharmacy Physical Medicine Preventive Medicine Pulmonary Radiology, diagnostic Radiation Therapy Transplant Women's Health
Administrative
Reimbursement Policies
Pharmacy
Dental
New Policies
Updated Policies
Upcoming Policies
| Policy | Name | Effective Date | Revision Date | Next Review Date | |
|---|---|---|---|---|---|
| D | |||||
| mp-026 | Drug Levels and Antibody Testing for Infliximab, Adalimumab, Vedolizumab and Ustekinumab | September 20, 2021 | July 15, 2021 | July 15, 2022 | |
| H | |||||
| MP-055 | Homocysteine Level Testing | September 26, 2021 | July 26, 2021 | July 26, 2022 | |
| V | |||||
| MP-056 | Vitamin D Testing | June 16, 2021 | June 16, 2021 | June 16, 2022 | |